Evaluation of the antifungal effect of thymoquinone on standard Candida strains and cytotoxicity on the fibroblastic cell line, in vitro study: Short Communication

Golzar Yadegary, Safiyeh; Ghasemi, Fahimeh; Nikoomanesh, Fatemeh

doi:10.61186/JBUMS.31.3.234

Volume 31, Issue 3 (November 2024) J Birjand Univ Med Sci. 2024, 31(3): 234-241 | Back to browse issues page

‎ 10.61186/JBUMS.31.3.234

Research code: 456782

Ethics code: IR. BUMS. REC. 1401.144

Mendeley

Zotero

RefWorks

Golzar Yadegary S, Ghasemi F, Nikoomanesh F. Evaluation of the antifungal effect of thymoquinone on standard Candida strains and cytotoxicity on the fibroblastic cell line, in vitro study: Short Communication. J Birjand Univ Med Sci. 2024; 31 (3) :234-241
URL: http://journal.bums.ac.ir/article-1-3435-en.html

Evaluation of the antifungal effect of thymoquinone on standard Candida strains and cytotoxicity on the fibroblastic cell line, in vitro study: Short Communication

Safiyeh Golzar Yadegary¹

, Fahimeh Ghasemi²

, Fatemeh Nikoomanesh ^*³

1- Student Research Committee, Birjand University of Medical Sciences, Birjand, Iran
2- Department of Medical Biotechnology, School of Medicine, Birjand University of Medical Sciences, Birjand, Iran
3- Cellular and Molecular Research Center, Birjand University of Medical Sciences, Birjand, Iran , g.nikoomanesh@yahoo.com

Abstract: (874 Views)

The present study aimed to assess the antifungal effect and compare different concentrations of thymoquinone on standard Candida strains, including Candida albicans, Candida glabrata, Candida parapsilopsis, and Candida tropicalis, and investigate the toxicity of thymoquinone on fibroblastic cell lines in laboratory conditions. The present in vitro study was designed to determine the minimum inhibitory concentration (MIC) and minimal fungicidal concentration (MFC) of thymoquinone in dilutions of 0.13-70 μg/ml on four yeast strains of Candida including Candida albicans (ATCC 10231), Candida glabrata (ATCC2001), Candida tropicalis (ATCC 200956), and Candida parapsilosis (ATCC22019) by broth microdilution method. The MTT test was used to evaluate the cytotoxicity of thymoquinone and fibroblast cell line. The results of MIC and MFC examinations of thymoquinone demonstrated that Candida albicans is more sensitive than other strains to thymoquinone (MIC: 2.18 µg/ml, MFC: 4.37 µg/ml) and cytotoxicity of thymoquinone on fibroblast cell line illustrated that the lowest toxicity was in 31.72 µg/ml and the highest toxicity was in 13.07 µg/ml. As a result, according to the MIC and MFC, these concentrations were non-toxic on the fibroblast cell line. As evidenced by the results of the present study, thymoquinone in specified concentrations had an inhibitory and fungicidal effect on Candida strains with the most negligible toxicity on the fibroblastic cell line.

Keywords: Candida spp, Cytotoxicity, In vitro, Thymoquinone

Full-Text [PDF 370 kb] (265 Downloads) | | Full-Text (HTML) (192 Views)

Type of Study: Short Communication | Subject: Mycology
Received: 2024/06/26 | Accepted: 2024/09/29 | ePublished ahead of print: 2024/10/15 | ePublished: 2024/12/5

References

1. Roudbary M, Kumar S, Kumar A, Cernáková L, Nikoomanesh F, Rodrigues CF. Overview on the Prevalence of Fungal Infections, Immune Response, and Microbiome Role in COVID-19 Patients. J. Fungi. 2021; 7(9): 720.DOI: 10.3390/jof7090720 [DOI:10.3390/jof7090720] [PMID] []

2. Kadkhodaei M, Sharif MR, Saba MA, Mousavi GA. Assessing the nosocomial infections'rate and the antibiotic resistance pattern among the patient hospitalized in Beheshti Hospital during 2013. Int Arch Health Sci. 2018; 5(1): 11-5. DOI: 10.4103/iahs.iahs_39_17 [DOI:10.4103/iahs.iahs_39_17]

3. Ebrahimzadeh A, Allahyari E, Nikoomanesh F, Zare_Bidaki M. A Comparative Analysis of Nosocomial Infections between Internal and Surgical Intensive Care Units of a University Hospital in Birjand, Iran from 2015 to 2016: A Retrospective Study. J Bas Res Med Sci. 2021; 8(4):32-41 DOI: 10.21203/rs.3.rs-42477/v1 [DOI:10.21203/rs.3.rs-42477/v1]

4. Erboga M, Kanter M, Aktas C, Sener U, Erboga ZF, Donmez YB, et al. Thymoquinone ameliorates cadmium-induced nephrotoxicity, apoptosis, and oxidative stress in rats is based on its anti- apoptotic and anti-oxidant properties. Biol Trace Elem Res. 2016; 170(1): 165-72. DOI: 10.1007/s12011-015-0453-x [DOI:10.1007/s12011-015-0453-x] [PMID]

5. Nouri N, Mohammadi SR, Beardsley J, Aslani P, Ghaffarifar F, Roudbary M, et al. Thymoquinone Antifungal Activity against Candida glabrata Oral Isolates from Patients in Intensive Care Units-An In Vitro Study. Metabolites. 2023; 13(4): 580. DOI: 10.3390/metabo13040580 [DOI:10.3390/metabo13040580] [PMID] []

6. Khan MA, Aldebasi YH, Alsuhaibani SA, AlSahli MA, Alzohairy MA, Khan A, et al. Therapeutic potential of thymoquinone liposomes against the systemic infection of Candida albicans in diabetic mice. PLoS One. 2018; 13(12): e0208951. DOI: 10.1371/journal.pone.0208951 [DOI:10.1371/journal.pone.0208951] [PMID] []

7. Ksiezopolska E, Gabaldón T. Evolutionary emergence of drug resistance in Candida opportunistic pathogens. Genes. 2018; 9(9): 461. DOI: 10.3390/genes9090461 [DOI:10.3390/genes9090461] [PMID] []

8. dos Santos ER, Dal Forno CF, Hernandez MG, et al Suscetibilidade de Candida spp. isoladas de hemocultivos, Avaliadas pelos breakpoints dos documentos M27-A3 e M27-S4 do CLSI. Rev Inst Med Trop Sao Paulo. 2014; 56(6): 477-82. DOI: 10.1590/S0036-46652014000600004 [DOI:10.1590/S0036-46652014000600004] [PMID] []

9. Zarimeidani R, Roudbar mohammadi‎ S, Roudbary M, Nikoomanesh F, Aslani P, Yaalimadad S. In-Vitro Antifungal Activity of Nano Encapsulated Caprylic Acid and EFG1 Gene Expression Profile in Candida albicans. Infect epidemiol microbiol. 2021; 7(3): 229-36. DOI: 10.52547/iem.7.3.229 [DOI:10.52547/iem.7.3.4]

10. Fisher MC, Alastruey-Izquierdo A, Berman J, Bicanic T, Bignell EM, Bowyer P, et al. Tackling the emerging threat of antifungal resistance to human health. Nat Rev Microbiol. 2022; 20(9): 557-71 DOI: 10.1038/s41579-022-00720-1 [DOI:10.1038/s41579-022-00720-1] [PMID] []

11. Beardsley J, Halliday CL, Chen SC, Sorrell TC. Responding to the emergence of antifungal drug resistance: perspectives from the bench and the bedside. Future Microbiol. 2018; 13(10): 1175-91. DOI: 10.2217/fmb-2018-0059 [DOI:10.2217/fmb-2018-0059] [PMID] []

12. Rahsepar S, Delavari H, Roudbari M, Mohammad Hassan Z. Design and Synthesis of Novel Thymoquinone-Zein Nanoparticles; Evaluation of the Inhibitory Effect on Candida albicans and Biofilm Formation in Vitro. Infect. epidemiol. microbiol. 2022; 8(2): 169-76. DOI: 10.52547/iem.8.2.169 [DOI:10.52547/iem.8.2.169]

13. Almshawit H, Macreadie I. Fungicidal effect of thymoquinone involves generation of oxidative stress in Candida glabrata. Microbiol Res. 2017; 195: 81-8. DOI: 10.1016/j.micres.2016.11.008 [DOI:10.1016/j.micres.2016.11.008] [PMID]

14. Kaypetch R, Rudrakanjana P, Churnjitapirom P, Tua-Ngam P, Tonput P, Tantivitayakul P. Geraniol and thymoquinone inhibit Candida spp. biofilm formation on acrylic denture resin without affecting surface roughness or color. J Oral Sci. 2022; 64(2): 161-6. DOI: 10.2334/josnusd.21-0435 [DOI:10.2334/josnusd.21-0435] [PMID]

15. Malani A, Hmoud J, Chiu L, Carver PL, Bielaczyc A, Kauffman CA. Candida glabrata fungemia: experience in a tertiary care center. Clinical infectious diseases. 2005; 41(7): 975-81. DOI: 10.1086/432939 [DOI:10.1086/432939] [PMID]